|
|
|
|
|
|
Atara Biotherapeutics- Inc. (ATRA)
|
|
15.10 +0.50 (+3.42%)
|
10/23/2017 11:02am
|
|
Open:
|
14.55
|
Pre. Close:
|
14.60
|
|
High:
|
15.20
|
Low:
|
14.43
|
|
Volume:
|
49,207
|
Market Cap:
|
461.44M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.89 - 15.37
|
15.37 - 15.85
|
|
Low:
|
13.63 - 13.78
|
13.78 - 13.94
|
|
Close:
|
14.35 - 14.89
|
14.89 - 15.42
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-23 11:14:23 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.
|
|
Target:
|
Six months: 18.82 One year: 20.38
|
|
Support:
|
Support1: 13.95 Support2: 11.61
|
|
Resistance:
|
Resistance1:
16.11 Resistance2: 17.45
|
|
Pivot:
|
15.28 
|
|
Moving Averages:
|
MA(5): 14.58 MA(20): 15.65
MA(100): 14.83 MA(250): 15.91
|
|
MACD:
|
MACD(12,26):
-0.28 Signal(12,26,9): -0.13
|
|
%K %D:
|
%K(14,3): 20.95 %D(3): 13.48
|
|
RSI:
|
RSI(14): 48.01
|
|
52-Week:
|
High: 23.00
Low: 11.80 Change(%): 7.1
|
|
Average Vol(K):
|
3-Month: 17115
10-Days 11053
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ATRA has closed above bottom band by 45.0%. Bollinger Bands are 45% wider than normal. The large width of the bands suggest high volatility as compared to ATRA's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Thu, 19 Oct 2017 12:00:00 GMT
Atara Biotherapeutics Initiates 60 Patient, Global Phase 1 Clinical Study to ...
Mon, 11 Sep 2017 12:00:00 GMT
Atara Biotherapeutics Receives Positive Health Canada Regulatory Feedback for ...
Tue, 22 Aug 2017 12:00:00 GMT
Atara Biotherapeutics Expands Leadership Team with the Appointment of Dr ...
Thu, 31 Aug 2017 20:15:00 GMT
Atara Biotherapeutics to Participate in Three Upcoming Investor Conferences
Mon, 07 Aug 2017 20:03:45 GMT
Atara Biotherapeutics Announces Second Quarter 2017 Financial Results and ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
